Cipla announces Q2 FY1415 Unaudited Consolidated Financial Results

Cipla appoints Ms.Punita Lal and Dr. Nachiket Mor as Independent Directors on its Board

Cipla Medpro announces collaboration with world’s largest generic pharmaceutical company

The Medicines Patent Pool Adds New Sub-Licensing Agreements to Improve Access to Novel ARVs in Developing Countries

Cipla strengthens its presence in Kenya

Cipla licenses rights for innovative product

Cipla enters into a licensing agreement with Gilead to increase access to Hepatitis C treatment

Cipla announces a commercial collaboration with S&D Pharma to enter Czech Republic and Slovakia with affordable high quality alternatives

Cipla enters the respiratory market in Germany and Sweden with affordable high quality alternatives

Cipla announces Q1 FY1415 Unaudited Consolidated Financial Results